Controlled delivery of naltrexone by an intraoral device: In vivo study on human subjects

International Journal of Pharmaceutics

Volumn 452, Issue 1-2, 2013, Pages 128-134

  Paderni, Carlo ^a   Campisi, Giuseppina ^a,b   Schumacher, Axel ^b,c   Goẗtsche, Thorsten ^b,c   Giannola, Libero Italo ^a,b   De Caro, Viviana ^a   Wolff, Andy ^b,d  

^a UNIVERSITY OF PALERMO   (Italy)

^b IntelliDrug Consortium   (Germany)

^c HSG IMIT Institut für Mikro und Informationstechnik der Hahn Schickard Gesellschaft EV   (Germany)

^d ASSUTA MEDICAL CENTER   (Israel)

Author keywords

Addiction; Naltrexone hydrochloride; Smoking cessation; Transbuccal drug delivery; Transmucosal delivery

Indexed keywords

NALTREXONE;

ADULT; ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IN VIVO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TABLET;

EID: 84884205240     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.04.070     Document Type: Article

References (29)

1. Birudaraj, R., Berner, B., Shen, S., Li, X., 2005. Buccal permeation of buspirone: mechanistic studies on transport pathways. J. Pharm. Sci. 94, 70-78. (Pubitemid 40116371)
2. Campisi, G., Giannola, L.I., Florena, A.M., De Caro, V., Schumacher, A., Gottsche, T., Paderni, C., Wolff, A., 2010a. Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: a trial on pigs. J. Control. Release 145, 214-220.
3. Campisi, G., Paderni, C., Saccone, R., Di Fede, O., Wolff, A., Giannola, L.I., 2010b. Human buccal mucosa as an innovative site of drug delivery. Curr. Pharm. Des. 16, 641-652.
4. Ceschel, G.C., Maffei, P., Moretti, M.D., Demontis, S., Peana, A.T., 2000. In vitro permeation through porcine buccal mucosa of Salvia desoleana Atzei and Picci essential oil from topical formulations. Int. J. Pharm. 195, 171-177. (Pubitemid 30089501)
5. Ceschel, G.C., Maffei, P., Sforzini, A., Lombardi Borgia, S., Yasin, A., Ronchi, C., 2002. In vitro permeation through porcine buccal mucosa of caffeic acid phenetyl ester (CAPE) from a topical mucoadhesive gel containing propolis. Fitoterapia 73, S44-S52. (Pubitemid 35472203)
6. Comer, S.D., Sullivan, M.A., Yu, E., Rothenberg, J.L., Kleber, H.D., Kampman, K., Dackis, C., O'Brien, C.P., 2006. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch. Gen. Psychiatry 63, 210-218. (Pubitemid 43213883)
7. David, S., Lancaster, T., Stead, L.F., 2001. Opioid antagonists for smoking cessation. Cochrane Database Syst. Rev., CD003086 (Online).
8. Desai, K.G., Kumar, T.M., 2004. Preparation and evaluation of a novel buccal adhesive system. AAPS PharmSciTech 5, e35.
9. Giannola, L.I., De Caro, V., Giandalia, G., Siragusa, M.G., Campisi, G., Florena, A.M., Ciach, T., 2007a. Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features. Eur. J. Pharm. Biopharm. 65, 238-246. (Pubitemid 46038078)
10. Giannola, L.I., De Caro, V., Giandalia, G., Siragusa, M.G., Tripodo, C., Florena, A.M., Campisi, G., 2007b. Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design. Eur. J. Pharm. Biopharm. 67, 425-433. (Pubitemid 47211903)
11. Hoogstraate, A.J., Cullander, C., Nagelkerke, J.F., Senel, S., Verhoef, J.C., Junginger, H.E., Bodde, H.E., 1994. Diffusion rates and transport pathways of fluorescein isothiocyanate (FITC)-labeled model compounds through buccal epithelium. Pharm. Res. 11, 83-89. (Pubitemid 24040768)
12. Hulse, G.K., Morris, N., Arnold-Reed, D., Tait, R.J., 2009. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone. Arch. Gen. Psychiatry 66, 1108-1115.
13. Jasti, B.R., Zhou, S., Mehta, R.C., Li, X., 2000. Permeability of antisense oligonucleotide through porcine buccal mucosa. Int. J. Pharm. 208, 35-39.
14. Jayaram-Lindstrom, N., Hammarberg, A., Beck, O., Franck, J., 2008. Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. Am. J. Psychiatry 165, 1442-1448.
15. Kornor, H., Waal, H., 2005. From opioid maintenance to abstinence: a literature review. Drug Alcohol Rev. 24, 267-274. (Pubitemid 41451937)
16. Krupitsky, E.M., Blokhina, E.A., 2010. Long-acting depot formulations of naltrexone for heroin dependence: a review. Curr. Opin. Psychiatry 23, 210-214.
17. Liu, C., Xu, H.N., Li, X.L., 2002. In vitro permeation of tetramethylpyrazine across porcine buccal mucosa. Acta Pharmacol. Sin. 23, 792-796. (Pubitemid 35012980)
18. Lobmaier, P.P., Kunoe, N., Gossop, M., Waal, H., 2010. Naltrexone depot formulations for opioid and alcohol dependence: a systematic review. CNS Neurosci. Ther.
19. Mashru, R., Sutariya, V., Sankalia, M., Sankalia, J., 2005. Transbuccal delivery of lamotrigine across porcine buccal mucosa: in vitro determination of routes of buccal transport. J. Pharm. Pharm. Sci. 8, 54-62. (Pubitemid 41528870)
20. Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., Verster, A., 2011. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst. Rev., CD001333 (Online).
21. Myrick, H., Anton, R., 2004. Recent advances in the pharmacotherapy of alcoholism. Curr. Psychiatry Rep. 6, 332-338. (Pubitemid 39591813)
22. Nicolazzo, J.A., Reed, B.L., Finnin, B.C., 2005. Buccal penetration enhancers-how do they really work? J Control Rel 105, 1-15. (Pubitemid 40805471)
23. Scholz, O.A., Wolff, A., Schumacher, A., Giannola, L.I., Campisi, G., Ciach, T., Velten, T., 2008. Drug delivery from the oral cavity: focus on a novel mechatronic delivery device. Drug Discov. Today 13, 247-253.
24. Valiveti, S., Paudel, K.S., Hammell, D.C., Hamad, M.O., Chen, J., Crooks, P.A., Stinchcomb, A.L., 2005. In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs. Pharm. Res. 22, 981-989. (Pubitemid 40898108)
25. Verebey, K., 1981. The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics. NIDA Res. Monogr. 28, 147-158. (Pubitemid 12235218)
26. Wagner, R.S., Nelson, L.B., 2010. Keeping ahead of the times. J. Pediatr. Ophthalmol. Strabismus 47, 204.
27. Whooley, M.A., Avins, A.L., Miranda, J., Browner, W.S., 1997. Case-finding instruments for depression, two questions are as good as many. J. Gen. Intern. Med. 12, 439-445. (Pubitemid 27300561)
28. Xiang, J., Fang, X., Li, X., 2002. Transbuccal delivery of 2′,3′-dideoxycytidine: in vitro permeation study and histological investigation. Int. J. Pharm. 231, 57-66. (Pubitemid 33086819)
29. Yin, W., Akala, E.O., Taylor, R.E., 2002. Design of naltrexone-loaded hydrolysable crosslinked nanoparticles. Int. J. Pharm. 244, 9-19. (Pubitemid 35245442)